1.
ABC of cancer care. (Wiley-Blackwell, 2013).
2.
Carlo, P. ABC of Cancer Care. (John Wiley & Sons, Incorporated, 2013).
3.
Cabot, Richard CHarris, Nancy Lee, MDRosenberg, Eric S, MDShepard, Jo-Anne O, MDCort, Alice M, MD. Case 14-2013. The New England Journal of Medicine 368, 1827–1835.
4.
Kaye, P. Breaking bad news: a 10 step approach. (EPL, 1996).
5.
Jonathan Silverman, Suzanne Kurtz, and Juliet Draper. Skills for Communicating with Patients, 3rd Edition. (Chapman and Hall/CRC, 2016).
6.
Silverman, J., Kurtz, S. M. & Draper, J. Skills for communicating with patients. (Radcliffe Publishing, 2013).
7.
Kurtz, S. M., Silverman, J. & Draper, J. Teaching and learning communication skills in medicine. (Radcliffe, 2005).
8.
Adler, D. D., Riba, M. B. & Eggly, S. Breaking Bad News in the Breast Imaging Setting. Academic Radiology 16, 130–135 (2009).
9.
Fujimori, M. & Uchitomi, Y. Preferences of Cancer Patients Regarding Communication of Bad News: A Systematic Literature Review. Japanese Journal of Clinical Oncology 39, 201–216 (2009).
10.
Hanratty, BarbaraLowson, ElizabethHolmes, LouiseGrande, GunnJacoby, Ann. Breaking bad news sensitively: what is important to patients in their last year of life? BMJ Supportive & Palliative Care 2, 53–59.
11.
Hamilton, W. The CAPER studies: five case-control studies aimed at identifying and quantifying the risk of cancer in symptomatic primary care patients. The British Journal of Cancer 101,.
12.
Alfred G. Knudson, Jr. Mutation and Cancer: Statistical Study of Retinoblastoma. Proceedings of the National Academy of Sciences of the United States of America 68, (1971).
13.
Gawande, A. & Wellcome Collection. Being mortal: illness, medicine and what matters in the end. (Profile Books, 2015).
14.
Being Mortal. https://sussex-primo.hosted.exlibrisgroup.com/primo-explore/fulldisplay?docid=44SUS_ALMA_DS51112977480002461&context=L&vid=44SUS_VU1&search_scope=44SUS_LIBRARY&isFrbr=true&tab=default&lang=en_US (2014).
15.
Mukherjee, S. The emperor of all maladies: a biography of cancer. (Fourth Estate, 2011).
16.
Clark, S. A guide to cancer genetics in clinical practice. (TFM, 2009).
17.
Firth, H. V., Hurst, J. A. & Hall, J. G. Oxford desk reference: clinical genetics. (Oxford University Press, 2005).
18.
Gene Reviews via the NCBI website : National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/.
19.
OMIM - Online Mendelian Inheritance in Man. https://omim.org/.
20.
Sorace, J. et al. Integrating pathology and radiology disciplines: an emerging opportunity? BMC Medicine 10, (2012).
21.
Royal College of Pathologists datasets for histopathology reporting on cancers. https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html.
22.
Hanahan, D. & Weinberg, R. A. The Hallmarks of Cancer. Cell 100, 57–70 (2000).
23.
Husband, J. E. & Reznek, R. H. Husband & Reznek’s imaging in oncology. (Informa Healthcare, 2010).
24.
American Joint Committee on Cancer. AJCC cancer staging handbook: from the AJCC Cancer staging manual. (Springer, 2010).
25.
Grégoire, V. et al. Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiotherapy and Oncology 110, 172–181 (2014).
26.
Li, B., Li, Q., Nie, W. & Liu, S. Diagnostic value of whole-body diffusion-weighted magnetic resonance imaging for detection of primary and metastatic malignancies: A meta-analysis. European Journal of Radiology 83, 338–344 (2014).
27.
Whole-Body Diffusion-Weighted MRI: Tips, Tricks, and Pitfalls: American Journal of Roentgenology. American Journal of Roentgenology.
28.
Goh V, Ng QS, Miles K. Computed tomography perfusion imaging for therapeutic assessment: has it come of age as a biomarker in oncology? 47, (2012).
29.
Imaging for Staging and Response Assessment in Lymphoma : Radiology.
30.
Cheson, B. D. et al. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification. Journal of Clinical Oncology 32, 3059–3067 (2014).
31.
Dimopoulos, M. A. et al. Role of Magnetic Resonance Imaging in the Management of Patients With Multiple Myeloma: A Consensus Statement. Journal of Clinical Oncology 33, 657–664 (2015).
32.
Dow-Mu Koh, Matthew Blackledge & Anwar R. Padhani et al. Whole-Body Diffusion-Weighted MRI: Tips, Tricks, and Pitfalls.
33.
Berland, L. L. et al. Managing Incidental Findings on Abdominal CT: White Paper of the ACR Incidental Findings Committee. Journal of the American College of Radiology 7, 754–773 (2010).
34.
Gore, R. M. et al. The incidental cystic pancreas mass: a practical approach. Cancer Imaging 12, 414–421 (2012).
35.
Personalized Tumor Response Assessment in the Era of Molecular Medicine: Cancer-Specific and Therapy-Specific Response Criteria to Complement Pitfalls of RECIST : American Journal of Roentgenology.
36.
Eisenhauer, E. A. et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). European Journal of Cancer 45, 228–247 (2009).
37.
Response Criteria in Oncologic Imaging: Review of Traditional and New Criteria : RadioGraphics.
38.
A Radiologist’s Guide to Treatment Response Criteria in Oncologic Imaging: Anatomic Imaging Biomarkers : American Journal of Roentgenology.
39.
Neoplastic Invasion of Laryngeal Cartilage: Reassessment of Criteria for Diagnosis at MR Imaging.
40.
Vardy, J. et al. Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature. British Journal of Cancer 91, 1045–1049 (2004).
41.
Mehanna, HishamWong, Wai-LupMcConkey, Christopher CRahman, Joy KRobinson, Max. PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer. The New England Journal of Medicine 374, 1444–1454.
42.
Balaji Ganeshan. Quantifying tumour heterogeneity with CT. Cancer Imaging 13, (2013).
43.
British Thyroid Association Guidelines. https://www.british-thyroid-association.org/current-bta-guidelines-and-statements.
44.
British Thoracic Society Guidelines for the investigation and management of pulmonary nodules. https://www.brit-thoracic.org.uk/document-library/clinical-information/pulmonary-nodules/bts-guidelines-for-pulmonary-nodules/.
45.
NICE Suspected cancer: recognition and referral | Guidance and guidelines.
46.
Fleissig, AnneJenkins, ValerieCatt, SusanFallowfield, Lesley. Multidisciplinary teams in cancer care: are they effective in the UK? Lancet Oncology 7, 935–43.
47.
Munro, A. J. Multidisciplinary Team Meetings in Cancer Care: An Idea Whose Time has Gone? Clinical Oncology 27, 728–731 (2015).
48.
Jalil, R., Ahmed, M., Green, J. S. A. & Sevdalis, N. Factors that can make an impact on decision-making and decision implementation in cancer multidisciplinary teams: An interview study of the provider perspective. International Journal of Surgery 11, 389–394 (2013).
49.
Lamb, B., Payne, H., Vincent, C., Sevdalis, N. & Green, J. S. A. The role of oncologists in multidisciplinary cancer teams in the UK: an untapped resource for team leadership? Journal of Evaluation in Clinical Practice 17, 1200–1206 (2011).
50.
NHS Cancer Action Team: Quality in Nursing: Excellence in Cancer Care: The contribution of the Clinical Nurse Specialist. https://www.macmillan.org.uk/documents/aboutus/commissioners/excellenceincancercarethecontributionoftheclinicalnursespecialist.pdf.
51.
Clark, D. et al. Imminence of death among hospital inpatients: Prevalent cohort study. Palliative Medicine 28, 474–479 (2014).
52.
Costantini, M. et al. Liverpool Care Pathway for patients with cancer in hospital: a cluster randomised trial. The Lancet 383, 226–237 (2014).
53.
Campion, Edward WKelley, Amy SMorrison, R Sean. Palliative Care for the Seriously Ill. The New England Journal of Medicine 373, 747–755.
54.
May, P. et al. Prospective Cohort Study of Hospital Palliative Care Teams for Inpatients With Advanced Cancer: Earlier Consultation Is Associated With Larger Cost-Saving Effect. Journal of Clinical Oncology 33, 2745–2752 (2015).
55.
Temel, Jennifer S, MDGreer, Joseph A, PhDMuzikansky, Alona, MAGallagher, Emily R, RNAdmane, Sonal, MB, BS, MPH. Early Palliative Care for Patients with Metastatic Non-Small-Cell Lung Cancer. The New England Journal of Medicine 363, 733–42.
56.
National Confidential Enquiry into Patient Outcome and Death.
57.
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. The New England Journal of Medicine 365, 395–409.
58.
Black, William CGareen, Ilana FSoneji, Samir SSicks, JoRean DKeeler, Emmett B. Cost-Effectiveness of CT Screening in the National Lung Screening Trial. The New England Journal of Medicine 371, 1793–802.
59.
Jefford, M. et al. Implementing improved post-treatment care for cancer survivors in England, with reflections from Australia, Canada and the USA. British Journal of Cancer 108, 14–20 (2013).
60.
Living with and Beyond Cancer. Taking Action to Improve Outcomes.
61.
DeVita, Hellman, and Rosenberg’s cancer: principles & practice of oncology. (Wolters Kluwer, 2015).
62.
DeVita, Hellman, and Rosenberg’s Cancer : Principles & Practice of Oncology. (Wolters Kluwer Health, 2014).
63.
Hoskin, P. J. External beam therapy. vol. Radiotherapy in practice (Oxford University Press, 2012).
64.
Hoskin, P. J. & Coyle, C. Brachytherapy. vol. Radiotherapy in practice (Oxford University Press, 2011).
65.
Hoskin, P. J. & Goh, V. Imaging. vol. Radiotherapy in practice (Oxford University Press, 2009).
66.
Hoskin, P. J. Radioisotope therapy. vol. Radiotherapy in practice (Oxford University Press, 2007).
67.
Practical Radiotherapy Planning: Contouring Atlases. https://www.rtog.org/CoreLab/ContouringAtlases.aspx.
68.
Arends, J. et al. ESPEN Guidelines on Enteral Nutrition: Non-surgical oncology. Clinical Nutrition 25, 245–259 (2006).
69.
Burnet, N. G. Defining the tumour and target volumes for radiotherapy. Cancer Imaging 4, 153–161 (2004).
70.
Tokuhashi, Y., Matsuzaki, H., Oda, H., Oshima, M. & Ryu, J. A Revised Scoring System for Preoperative Evaluation of Metastatic Spine Tumor Prognosis. Spine 30, 2186–2191 (2005).
71.
Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition | Guidance and guidelines | NICE.
72.
Metastatic spinal cord compression in adults | Guidance and guidelines | NICE.
73.
Neutropenic sepsis: prevention and management in people with cancer | Guidance and guidelines | NICE.
74.
NICE IPG79 (2004) Stent placement for vena caval obstruction.
